Twist Bioscience Corporation (FRA:0ME)

Revenue by Product

Financials in millions USD. Fiscal year is October - September.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020	Sep 30, 2019	Sep 30, 2018	Sep 30, 2017
Next Generation Sequencing Tools	169.13M
Next Generation Sequencing Tools Growth	36.72%
Synthetic Genes	92.68M
Synthetic Genes Growth	26.02%
Antibody Discovery	20.33M
Antibody Discovery Growth	-12.27%
Oligo Pools	16.91M
Oligo Pools Growth	16.68%
DNA Libraries	13.93M
DNA Libraries Growth	36.58%

Revenue by Geography

Financials in millions USD. Fiscal year is October - September.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020	Sep 30, 2019	Sep 30, 2018	Sep 30, 2017
United States	187.78M
United States Growth	27.69%
EMEA	92.57M
EMEA Growth	29.67%
APAC	26.52M
APAC Growth	18.11%
Americas	6.10M
Americas Growth	45.31%